An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

NCT01536418 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: GSK1605786A
DRUG: GSK1605786A

Sponsor

GlaxoSmithKline